Key result
Immunosuppressive therapy successfully treated an infant presenting with parvovirus B19-associated fulminant myocarditis.
Reports a successful case of using immunosuppressive therapy for parvovirus B19-associated fulminant myocarditis in an infant.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in parvovirus B19 myocarditis; leaves open immunosuppression role pending controlled trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Veronese et al. (2022) studied this question. Immunosuppressive therapy successfully treated an infant presenting with parvovirus B19-associated fulminant myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: